Interleukin 12 (IL-12), a heterodimeric cytokine composed of p40 and p35 chains, has potent immunologic effects in vitro. We used tuberculous pleuritis as a model to study the immunoregulatory potential of IL-12 in vivo at the site of human infectious disease. Messenger RNAs for p40 and p35 were detected in pleural fluid from six of six patients by reverse-transcription polymerase chain reaction. By using an ELISA that detected both free p40 and heterodimeric IL-12, we found that mean concentrations were 585±89 pg/ml in pleural fluid of patients with tuberculous pleuritis, which were significantly higher than those in serum of the same patients (54±36 pg/ ml), or in malignant pleural effusions (123±35 pg/ml). By using an ELISA specific for heterodimeric IL-12, we found that mean concentrations in pleural fluid of patients with tuberculous pleuritis were 165±28 pg/ml and undetectable in serum of the same patients, or in malignant pleural effusions. Clin. Invest. 1994. 93:1733-1739
Introduction
IL-12, originally identified as natural killer (NK)' cell stimulatory factor and cytotoxic lymphocyte maturation factor, is a disulfide-linked heterodimeric cytokine composed of two subunits of molecular masses of 40 kD (p40) and 35 kD (p35) (1) (2) (3) (4) . Among the plethora ofcytokines produced by mononuclear cells, IL-12 has distinctive features that suggest an important role in human immune defenses against intracellular pathogens. IL-12 can elicit production of IFN--y by PBMC (2) . IL-12 is more potent than IL-2, IFN-,y, and IFN-a in enhancing NK cell-mediated cytotoxicity (2) , augments antigen-dependent proliferation by CD8+ cytotoxic T lymphocytes (5) , and facilitates development of Th 1 cells (6) (7) (8) (9) . Preliminary studies suggest that IL-12 enhances cytotoxicity by CD4' T cells against macrophages pulsed with Mycobacterium tuberculosis (10) . Despite IL-12's multiple immunoregulatory effects in vitro, there is little published information on its role in modulating the immune response in vivo.
Tuberculous pleuritis provides an excellent model to study the immune response in vivo. Inflammatory cells and pleural fluid are readily obtained from the site ofdisease, and immunologic reactivity against M. tuberculosis is compartmentalized in the pleural space. In pleural fluid, there is selective concentration ofantigen-reactive T lymphocytes ( 11 ) and cytokines with antimycobacterial activity, such as IFN-,y and TNF-a ( 12, 13). To gain insight into the immunoregulatory potential of IL-12 in vivo, we evaluated IL-12 production in the pleural fluid of patients with tuberculous pleuritis.
Methods
Patient population. Pleural fluid and blood were obtained from 15 patients with tuberculous pleuritis seen at the Los Angeles County-University of Southern California Medical Center. All patients had unilateral exudative effusions without clinical evidence of concomitant pulmonary tuberculosis or HIV infection. The diagnosis was confirmed either by pathologic demonstration of granulomatous pleuritis on closed pleural biopsy ( 10 cases) or growth of M. tuberculosis from pleural fluid or tissue (9 cases). All patients responded to antituberculosis therapy. The experiments described were performed on 5-9 of these 15 patients.
Pleural fluid was also obtained from 9 patients with pleural effusions resulting from malignancies. Blood was obtained from 10 healthy tuberculin reactors, 4 healthy tuberculin-negative persons, and 9 patients with culture-proven pulmonary tuberculosis.
Isolation ofRNA and cDNA synthesis. Freshly isolated pleural fluid mononuclear cells and PBMC from patients with tuberculous pleuritis were lysed with 4 M guanidinium isothiocyanate and stored at -20°C before preparation of RNA, which was isolated as previously described AG, 3': TGGGTCTATTCCGTTGTGTC; (c) p35 5': CCTCAGTTT-GGCCAGAAACC; 3': GGTCTTTCTGGAGGCCAGGC. PCR product was subjected to electrophoresis on 2% agarose gels and visualized by staining with ethidium bromide.
Hybridization ofPCR product. To confirm the specificity ofamplification of p40 mRNA, PCR product was transferred to Hybond-N nylon membranes (Amersham Corp., Arlington Heights, IL) and hybridized with a radioactive oligonucleotide probe complementary to sequences internal to those recognized by the p40-specific primers. The sequence of the probe is: TGGCTGAGGTCTTGTCCGTGAAGA-CTCTAT. The probe was labeled at the 5' end with T4 polynucleotide kinase (Boehringer Mannheim Biochemicals, Indianapolis, IN) and
[32P]yATP (7, 000 Ci/mM, ICN, Costa Mesa, CA). Blots were hybridized with probe for 4 h, washed for 5 min with 2x SSC and 0.5% SDS, then exposed to x-ray film. Membranes were scanned with a radioanalytic imaging system (AMBIS, Automated Microbiology Systems Inc., San Diego, CA).
Validity ofPCR amplification for semiquantitative comparison of IL-12 mRNA expression. A number of controls were employed to permit semiquantitative comparison of p40 mRNA expression in the pleural fluid and blood samples studied. Upon PCR amplification of serial fivefold dilutions of sample cDNAs, a concomitant decrease in PCR product was observed. Variation ofthe number ofPCR cycles did not change the relative differences between samples. These studies indicate that our PCR conditions are not within the plateau phase ofamplification. Each experiment included a positive control (cDNA from Staphylococcus aureus Cowan I strain-stimulated PBMC) and a negative control to which no cDNA was added. In addition, precautions were taken to avoid cross-contamination of samples, including assembling reactions in laminar flow hoods, use of aliquotted reagents, pipettes dedicated for assembling PCR (Fig. 2) . PCR product for p35 cDNA was present in all pleural fluid and blood samples. Increased expression of p40 mRNA in pleural fluid compared to blood was not due to increased total mRNA in the pleural fluid samples, in as much as PCR product for /-actin cDNA was comparable in pleural fluid and blood (Fig. 2) .
The specificity of PCR amplification of p40 cDNA was confirmed by transfer of PCR product to nylon membranes and hybridization to an internal 32P-labeled probe. All pleural fluid samples incorporated radioactivity (mean 7,108 cpm), and weak radioactivity incorporation was noted in two of six PBMC samples (mean 898 cpm, Fig. 3 ).
IL-12 in pleuralfluid. In order to determine whether selective mRNA expression for p40 in the pleural fluid reflected translation into protein, concentrations bf p40 and IL-12 were measured in pleural fluid and serum of nine patients with tuberculous pleuritis. The ELISA with 4A 1, which detects both heterodimeric IL-12 and free p40, revealed a mean pleural fluid concentration of 585±89 pg/ml, which was significantly higher than the mean concentration in serum of the same patients (54±36 pg/ml, P = 0.0003, Fig. 4 ), or in pleural fluid of nine patients with malignancy (123±35 pg/ml, P = 0.0005, Fig. 4 ). Using the ELISA with 20C2, which detects only heterodimeric IL-12, we found that the mean IL-12 concentration in pleural fluid was 165±28 pg/ml, with undetectable levels in serum of the same patients (P = 0.0004, Fig. 4 ), or in pleural fluid of patients with malignancy (P = 0.0001, Fig. 4) . The difference between the results obtained with these two ELISAs indicates the presence of significant levels of free p40 in the pleural fluid of patients with tuberculous pleuritis, consistent with previous observations that free p40 is produced in excess by cell lines that make bioactive heterodimeric IL-12 (3, 4, 17) . produced by mononuclear cells in response to M. tuberculosis. In order to determine whether IL-12 was produced by pleural fluid cells in response to M. tuberculosis, we used the ELISA with 4A1 to measure concentrations of free p40 and heterodimeric IL-12 in supernatants of pleural fluid cells and PBMC of five patients, stimulated with heat-killed M. tuberculosis (Fig. 5, top) . p40 and/or heterodimeric IL-12 were detectable in five of five pleural fluid supernatants (mean 825±351 pg/ml), and in two of five PBMC supernatants (mean 347±306 pg/ml). The ELISA with 20C2, specific for heterodimeric IL-12, showed detectable IL-12 in two of five pleural fluid supernatants and none ofthe PBMC supernatants (Fig. 5,   middle ). To confirm that the IL-12 detectable by ELISA was biologically active and to measure IL-12 concentrations lower than the limit of detection ofthe ELISAs, we used an antibody capture assay with IL-12-responsive Kit225/K6 cells. Bioactive IL-12 was detectable in five of five pleural fluid supernatants (mean 366±197 pg/ml), and in one offive PBMC supernatants (Fig. 5, bottom) . By means of these three assays, we found that no IL-12 oir p40 was detectable in supernatants of pleural fluid cells or PBMC cultured in the absence ofM. tuberculosis Erdman. IL-12 production by adherent cells in response to M. tuberculosis. To assess the possible contribution of IL-12 to protective immunity against M. tuberculosis, we compared IL-12 production by 10 healthy tuberculin reactors with a protective immune response and by 9 pulmonary tuberculosis patients with ineffective immunity. When PBMC were stimulated with M. tuberculosis, IL-12 was not detectable in cell culture supernatants (data not shown). Because IL-12 is a growth factor for T cells and NK cells, these cells may utilize IL-12 and prevent its detection. IL-12 is produced by monocytes but not by T cells or NK cells (17) . We therefore enriched for monocytes by obtaining adherent cells and stimulating them with M. tuberculosis. Adherent cells from healthy tuberculin reactors and from tuberculosis patients produced comparable concentrations of IL-12 and p40, as determined by the 4A1 ELISA (mean of 361± 116 vs. 140±57 pg/ml, respectively, P = 0.11, Fig. 6, top) . Concentrations of bioactive IL-12, measured by the antigen capture bioassay, were also comparable (mean of 24± 10 vs. 6±6 pg/ml, P = 0.14, Fig. 6, bottom) . When adherent cells from four healthy tuberculin-negative donors were stimulated with M. tuberculosis, concentrations of IL-12 and p40 by 4A1 ELISA were barely detectable (mean 39±18 pg/ml) and heterodimeric IL-12 was not detectable by bioassay. Because IL-4 and IL-10 inhibit IL-12 production (20, 21), we maximized our capacity to detect IL-12 by adding anti-IL-4 and anti-IL-10 antibodies to M. tuberculosis-stimulated cells. Under these conditions, the mean concentrations of IL-12 and p40 by 4A1 ELISA were 2,781±724 pg/ml in healthy tuberculin reactors, vs. 3,430±1,656 in tuberculosis patients (P = 0.74, Fig. 6, bottom) . The concentrations of heterodimeric IL-12 by bioassay were also similar ( 149±45 vs. 154±82, P = 0.96, Fig.  6, bottom) . In four healthy tuberculin-negative persons, parallel experiments yielded mean concentrations of IL-12 and p40 of 200±112 pg/ml, and undetectable concentrations of bioactive IL-12.
Effect ofanti-IL-12 antibodies on M. tuberculosis-induced proliferation. Because IL-12 was present in pleural fluid and was produced upon stimulation with M. tuberculosis, we wished to determine if IL-12 contributed to lymphocyte proliferation in response to mycobacterial antigens. Pleural fluid mononuclear cells from six patients were stimulated with heatkilled M. tuberculosis in culture, and the effects of adding a 50:50 mix of the neutralizing anti-IL-12 monoclonal antibod- (Fig. 7) . Addition of isotype control antibodies did not affect antigen-induced proliferation.
Discussion
The results presented in this report provide new evidence that IL-12 consists of p40 and p35 chains, both of which are required for bioactivity (1 (26, 27) , IFN-'y reduces the bacillary burden in lepromatous leprosy patients (28) and is a functional marker of murine T cells that confer adoptive immunity against tuberculosis (29, 30) . TNF-a augments the mycobactericidal capacity of human macrophages ( 31 ) and is essential for granuloma formation to contain murine mycobacterial infection (32) . Our (33) , and TNF induces IFN-y production by NK cells (34) , these cytokines may comprise a positive feedback cycle that yields high local cytokine concentrations, facilitating granuloma formation and bacillary elimination ( 13) .
Another potential means by which IL-12 could facilitate mycobacterial clearance is through favoring development of Th 1 cells which are thought to mediate resistance against mycobacteria (35, 36) . IL-12 induces differentiation of human and murine Th 1-like cells (6, 37) and can cure murine leishmaniasis through enhanced production of IFN--y (7, 38) . In tuberculous pleuritis, Th 1 cytokines predominate over Th2 cytokines in pleural fluid (39) turn favors differentiation ofprecursor T cells into ThI cells (8, 9, 40) . This effect may be mediated either directly by IL-12 or through stimulation of IFN-y production by NK cells and/or T cells. IL-12 may also enhance antimycobacterial immune defenses through its effects on cytolytic cells, which are thought to contribute to human immune defenses against M. tuberculosis (41 ). Mycobacterium tuberculosis induces antigen-specific cytotoxic CD4' T cells (42) and NK cells enhance mycobactericidal activity of macrophages in vitro (43) . In addition, antigen-specific cytolytic CD4' T cells and NK cells have been found at the site of disease in tuberculosis patients (44, 45) . Because IL-12 enhances cytotoxicity and augments proliferation by antigen-specific T cells and NK cells (5, 46, 47) , IL-12 may facilitate antigen-specific and nonspecific cytolytic immune defenses against intracellular pathogens, including M. tuberculosis. An intriguing property of IL-12 is its capacity to induce proliferation by cytolytic T cells only upon costimulation of the T cell receptor with antigen or anti-CD3 (5) . In contrast, cytokines such as IL-2 and IL-7 cause proliferation in the absence or presence of antigen (48) . IL-12 may thus be a candidate to control the cytolytic arm of the initial immune response to microbial pathogens by inducing expansion ofcytolytic T cells only when antigen is encountered.
In summary, IL-12 has the potential to contribute to immune defenses against M. tuberculosis and other intracellular pathogensby enhancing production ofIFN-'y, facilitating development ofTh 1 cells and orchestrating antigen-specific and nonspecific cytolytic mechanisms. Further investigations should clarify the functional role of IL-12 in vivo and its potential as an immunostimulatory agent in selected patients with tuberculosis and other infectious diseases.
